Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients

British Journal of Cancer

Volumn 94, Issue 5, 2006, Pages 681-685

  Nissan, A ^a   Jager, D ^b   Roystacher, M ^a   Prus, D ^a   Peretz, T ^a   Eisenberg, I ^a   Freund, H R ^a   Scanlan, M ^c   Ritter, G ^c   Old, L J ^c   Mitrani Rosenbaum, S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

Breast neoplasms; Mammaglobin; Micrometastases; NY BR 1; RT PCR

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 19; GLOBIN; MAMMOGLOBIN B; PROTEIN NY BR 1; RNA; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST METASTASIS; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE;

ADENOCARCINOMA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL;

EID: 33644836536     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602992     Document Type: Article

References (25)

1. Aihara T, Fujiwara Y, Ooka M, Sakita I, Tamaki Y, Monden M (1999) Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction. Breast Cancer Res Treat 58: 137-140
2. Becker RM, Darrow C, Zimonjic DB, Popescu NC, Watson MA, Fleming TP (1998) Identification of mammaglobin B, a novel member of the uteroglobin gene family. Genomics 54: 70-78
3. Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, Rjosk D, Hepp F (2001) Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 19: 1468-1475
4. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G, Schlimok G (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342: 525-533
5. Chao C (2004) The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer. Am Surg 70: 414-419
6. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM (1999) Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International breast cancer study group. Lancet 354: 896-900
7. Euhus DM (2003) Cytokeratin staining and other sentinel node controversies. Clin Breast Cancer 4(Suppl 1): S49-S54
8. Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Metcalf JS, Elliott BM, Brothers T, Robison J, Mitas M, Cole DJ (2004) Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg 239: 828-837
9. Gould VE, Bloom KJ, Franke WW, Warren WH, Moll R (1995) Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Virchows Arch 425: 617-629
10. Inokuchi M, Ninomiya I, Tsugawa K, Terada I, Miwa K (2003) Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br J Cancer 89: 1750-1756
11. International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335: 1565-1568
12. Ismail MS, Wynendaele W, Aerts JL, Paridaens R, Van Mellaert L, Anne J, Gaafar R, Shakankiry N, Khaled HM, Christiaens MR, Omar S, Vandekerckhove P, Van Oosterom AT (2003) Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutions. Ann Oncol 14: 1241-1245
13. Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT (2001) Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 61: 2055-2061
14. Kruger WH, Stockschlader M, Hennings S, Aschenbrenner M, Gruber M, Gutensohn K, Loliger C, Gieseking F, Jonat W, Zander AR (1996) Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant 18(Suppl 1): S18-S20
15. Li W, Stall A, Shivers SC, Haddad F, Messina J, Glass LF, Lyman G, Reintgen DS (2000) Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg 231: 795-803
16. Manhani AR, Manhani R, Soares HP, Bendit I, Lopes F, Nicoletti AG, Fonseca FL, Novaes M, Zatta SM, Arias V, Giralt S, del Giglio A (2001) CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy. Breast Cancer Res Treat 66: 249-254
17. Mansel RE, Goyal A (2004) European studies on breast lymphatic mapping. Semin Oncol 31: 304-310
18. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45: 2917-2924
19. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H (1996) Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction: comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 148: 649-656
20. Ooka M, Sakita I, Fujiwara Y, Tamaki Y, Yamamoto H, Aihara T, Miyazaki M, Kadota M, Masuda N, Sugita Y, Iwao K, Monden M (2000) Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients. Oncol Rep 7: 561-566
21. Ouellette RJ, Richard D, Maicas E (2004) RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastasis in sentinel lymph nodes. Am J Clin Pathol 121: 637-643
22. Posther KE, Wilke LG, Giuliano AE (2004) Sentinel lymph node dissection and the current status of American trials on breast lymphatic mapping. Semin Oncol 31: 426-436
23. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC (1994) Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986-2990
24. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, DeConti R, Cruse CW, Berman C, Fenske NA, Lyman GH, Reintgen DS (1998) Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 280: 1410-1415
25. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark GM, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL (2003) Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 83: 803-819